Clinical trial Recruiting at 1 site Observational Ages 18 and up

Observing outcomes of the Medacta Shoulder System

Official title: Clinical and Radiological Outcomes of Medacta Shoulder System

Run by Medacta International SA · NCT05926622 · Data updated 2026-11-12

This study is looking at how well the Medacta Shoulder System works and its safety for people with different shoulder problems.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorMedacta International SA
Industry-sponsored
Locations1 site (Annecy)
StatusRecruiting
StartedMarch 15, 2022
Main results expectedMarch 2032
Study endsMarch 2037
Registry record updatedSeptember 29, 2025
Trial IDNCT05926622 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old with specific shoulder diagnoses such as osteoarthritis or rotator cuff tear arthropathy.

Probably not a fit

Patients with malignant diseases, infections, or other significant functional deficits unrelated to the shoulder may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the clinical and radiological outcomes of the Medacta Shoulder System in patients with various shoulder conditions. It aims to gather data on the effectiveness and safety of this shoulder implant in real-world settings. The study will include patients diagnosed with primary and secondary osteoarthritis, rotator cuff tear arthropathy, rheumatoid arthritis, and other shoulder-related conditions. By monitoring these outcomes, the study seeks to provide insights into the long-term performance of the shoulder system.

Why it matters

Potential benefit: If successful, this study could enhance understanding of shoulder implant effectiveness, leading to improved treatment options for patients with shoulder conditions.

How similar studies have gone: While this study is observational and focuses on a specific implant, similar studies have shown success in evaluating the outcomes of shoulder arthroplasties.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients older than 18 years
* Patient with one of the following diagnosis:

Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty

Exclusion Criteria:

* Patients with malignant diseases (at the time of surgery)
* Patients with proven or suspect infections (at the time of surgery)
* Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery)
* Patients with known incompatibility or allergy to products materials (at the time of surgery)

Where it's running

  • Clinique Générale Annecy
    Annecy, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.